Play Video

OIS

The Ophthalmology Innovation Summit (OIS) was conceptualized and developed by ophthalmologist/venture capitalist Emmett Cunningham of Clarus Funds now Blackstone Life Sciences. To make his vision for OIS a reality, Emmett enrolled legendary venture capitalists, Bill Link of Versant Ventures/Flying L Partners to Co-Chair the summits. The addition of experienced conference producer, Craig Simak brought the event to life in 2009.

Learn More

QUOTE OF THE MONTH

"The only thing that makes a difference in life is when one individual takes a risk and says, I'm willing to be wrong and fail but I'm gonna go for it!" John P. Berdahl, MD

EVENT UPDATES

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LEARN MORE

The program will start off with a market overview followed by a showcase of 8 of the most promising start-ups in this sector and a deep-dive discussion with a panel of OD and MD KOLs on the viability of these products.

LEARN MORE

The program will kick off with hot topics in the retina space followed by a showcase of 8 ophthalmic companies presenting their latest clinical data and two lively panel discussions. One clinical and the other industry focused.

LEARN MORE

We will start with a showcase of ophthalmic start-ups followed by an overview of the EU innovation hotbeds and a panel of industry leaders to shed light on their internal and external efforts.

OIS Newsletter Subscribe graphic

TRENDING AT OIS

Discover the latest trending news, podcasts, videos from OIS covering corporate leaders and innovators.

Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary
August 5, 2020
The Lindstrom Method: Say ‘Yes’ to Opportunities
August 4, 2020
Dr. Ken Mandell’s Passion for Innovation
July 30, 2020
Virtual ASRS Reporter’s Notebook
July 30, 2020
‘A Very Interesting Time’ and Other Insights from OIS Virtual Public Company Showcase
July 22, 2020
The Lindstrom Method: Say ‘Yes’ to Opportunities
August 4, 2020
Dr. Ken Mandell’s Passion for Innovation
July 30, 2020
Paul Hallen’s View of Retina from the Catbird’s Seat
July 21, 2020
The Time is Nau!
July 15, 2020
OIS Israel Panel Dives Into Global Industry Insights and Innovation
July 9, 2020
Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary
August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol
July 9, 2020
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering
July 1, 2020
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery
April 29, 2020
Adverum, Gene Therapy, and AMD
March 25, 2020
OIS Index Rallies Back from COVID-Driven Decline
July 9, 2020
OIS Index Posts a Strong Finish to 2019
January 9, 2020
OIS Index Outperforms
December 4, 2019
OIS Index on Positive Upswing
November 6, 2019
OIS Index Deep in Bear Territory in Q3
October 2, 2019
Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Apply Today

The OIS All Stars of Ophthalmic Innovation

This is the inaugural ranking of individuals working to transform the current state of vision care. The nominees will be reviewed by a committee of OIS faculty, advisors and journalists. Once selected, the list of OIS All Stars will be published and widely promoted. Nominate your colleagues & peers here.

TESTIMONIALS

Why People Attend OIS

Daphne-Haim-Langford-PhD-OIS-Israel

TOM MITRO

PRESIDENT & COO

YARI MITCHELL

VP, GLOBAL MEDICAL AFFAIRS

JAG DOSANJH

SENIOR VICE PRESIDENT

SUBSCRIBE TO OUR NEWSLETTER

Get the Latest News Ophthalimc Innovation To Your Inbox.